All In MedTech

Device Trial Radar · NCT02710435

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Mar 2016

Primary completion

Nov 2023

Study completion Dec 2028

Sponsor

Lead sponsor
Shockwave Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 16, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect long term data of the Reducer System in subjects with refractory angina pectoris.

Conditions

  • Angina Pectoris
  • Angina Pectoris, Stable
  • Chronic Stable Angina

Interventions

  • Reducer SystemDevice

    An aid in the management of chronic refractory angina pectoris

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction in Canadian Cardiovascular Society (CCS) GradeTime frame: 6 Months

2 more outcomes with a free account

Locations

25 sites in 9 countries. Site status is shown where the registry gives one.

  • University of Graz

    Graz, Austria

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.